Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mitotic kinase expression and colorectal cancer progression.

Literature DB >> 10393726

Mitotic kinase expression and colorectal cancer progression.

H Katayama¹, T Ota, F Jisaki, Y Ueda, T Tanaka, S Odashima, F Suzuki, Y Terada, M Tatsuka.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10393726 DOI： 10.1093/jnci/91.13.1160

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

57 in total

Review 1. Understanding cytokinesis failure.

Authors: Guillaume Normand; Randall W King
Journal: Adv Exp Med Biol Date: 2010 Impact factor: 2.622

2. An integrated pharmacokinetic-pharmacodynamic model for an Aurora kinase inhibitor.

Authors: Hiroko Kamei; Robert C Jackson; Daniella Zheleva; Fordyce A Davidson
Journal: J Pharmacokinet Pharmacodyn Date: 2010-08-08 Impact factor: 2.745

3. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.

Authors: Vikas Sehdev; DunFa Peng; Mohammed Soutto; M Kay Washington; Frank Revetta; Jeffrey Ecsedy; Alexander Zaika; Tilman T Rau; Regine Schneider-Stock; Abbes Belkhiri; Wael El-Rifai
Journal: Mol Cancer Ther Date: 2012-02-01 Impact factor: 6.261

Review 4. Aurora kinases in head and neck cancer.

Authors: Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal: Lancet Oncol Date: 2013-09 Impact factor: 41.316

5. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.

Authors: Dimpy Koul; Jun Fu; Ruijun Shen; Tiffany A LaFortune; Shuzhen Wang; Ningyi Tiao; Yong-Wan Kim; Juinn-Lin Liu; Deepti Ramnarian; Ying Yuan; Carlos Garcia-Echevrria; Sauveur-Michel Maira; W K Alfred Yung
Journal: Clin Cancer Res Date: 2011-11-07 Impact factor: 12.531

6. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors: O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal: Strahlenther Onkol Date: 2012-02-08 Impact factor: 3.621

7. Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Authors: Teresa Troiani; Erika Martinelli; Floriana Morgillo; Anna Capasso; Anna Nappi; Vincenzo Sforza; Fortunato Ciardiello
Journal: Ther Adv Med Oncol Date: 2013-01 Impact factor: 8.168